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Abstract 
Use of in-vitro point of care devices – intended as tests performed out of laboratories and near 
patient – is increasing in clinical environments. International standards indicate that interaction 
assessment should not end after the product release, yet human factors methods are frequently 
not included in clinical and empirical studies of these devices. Whilst the literature confirms 
some advantages of bed-side tests compared to those in laboratories there is a lack of knowledge 
of the risks associated with their use. This article provides a review of approaches applied by 
clinical researchers to model the use of in-vitro testing. Results suggest that only a few studies 
have explored human factor approaches. Furthermore, when researchers investigated people-
device interaction these were predominantly limited to qualitative and not standardised 
approaches. The methodological failings and limitations of these studies, identified by us, 
demonstrate the growing need to integrate human factors methods in the medical field. 
 
Keywords: Acceptance, Clinical Studies, Ergonomics, Human Factors, In Vitro Test, 
Interaction, Point-of-care, POC, Satisfaction, Usability,  
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Introduction 
In vitro point of care (POC) testing are medical tools generally designed to be used near patient, 
or outside the traditional laboratory environment to rapidly inform diagnostic and clinical 
decisions [1-3]. Nowadays, a number of POC devices are used for a range of testing in clinical 
and home environments [4]. In 2013 the POC market was estimated to be $54 billion – i.e., 15% 
of the overall medical device market [5]. Evidence showed that the popularity of POC devices is 
linked to the fact that clinicians can save time and costs by rapidly, and comfortably testing 
people [4,6], thus increasing both patient’s satisfaction and clinician’s decision-making [7]. 
Moreover, POC tools are generally seen as a way to facilitate the self-management of chronic 
conditions, to improve the clinician-patient relationships [6], and to help patients comply with 
therapies [8]. Clinical experts are used to explore and assess the sensitivity and specificity of the 
POC devices in the real context of use, and including qualitative assessment of the acceptance 
and satisfaction of clinicians and patients [4,6,9,10]. Whilst significant concerns about the 
acceptance, usefulness, reliability and safety of the interaction with POC are clearly expressed in 
literature [6,8], these human factors variables are too often considered as only secondary aspects 
with an assumption that they have only a minimal impact on the device functioning and use.  
Gurses et al [11] identified that healthcare professionals and researchers are not fully aware of 
the methods and principles of human factors and ergonomics (HFE). HFE is the 
multidisciplinary science in which human behaviour, capacities and engineering principles are 
used to explore why errors occur, and how to reduce the likelihood of preventable harm to 
individuals, with the specific aim to support human performance and safety [12]. Professionals in 
the medical field are more likely to be focussed on enhancing diagnostic decision making, and on 
the comparison of POC devices with laboratory testing. Thus, medical studies have rarely looked 
at aspects such as the effect of user errors on decision making, or the effect of design issues on 
the safety in use and the reliability of a device.  
This lack of inclusion of HFE perspective in clinical studies may be due to the fact that 
healthcare professionals assume the devices are usable and safe because these tools are already 
available on the market, or because manufacturers, before the release, should have performed a 
full range of HFE analysis to verify and validate the device in keeping with international 
standards [13,14]. However, given the complexity of medical field 100% error free devices are 
not achievable [15] and the available data on product adverts events and medical recalls show 
that medical devices on the market may suffer from severe design issues that strongly affect 
diagnostic decisions and patient safety. For instance, in 2012 in the UK 13,549 patients were 
involved in device induced adverts events due to faulty system and human errors [16]. These 
events produced 305 fatal incidents and 4,417 serious injuries. Concurrently, recent data from 
USA suggested that, in 2014, 40% of the devices recalled from the market for safety reasons 
were affected by issues related to labelling, packaging and software functioning [17].  
As these data on device recalls and adverse events show clinicians and researchers, need to 
consider how to check both their interaction with the product (e.g., time and errors in use,) and 
also how patients react and perceive the product. Both are needed to fully assess the reliability of 
a POC device. Such is the variability of context of use and range of users that this will be 
necessary even when the manufacturer have provided reliable evidence that a device is well 
designed and safe. 
The current limited application of HFE approaches in clinical and comparative studies results in 
a limited knowledge of how much POC devices may be bringing medical errors closer to the 
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patients [18]. Recently researchers have investigated the interaction issues associated with POC 
devices by modelling the characteristics and error in the use of these devices [18,19]. Yet there is 
still a lack of inclusion in health studies of the methods and approaches required to assess HFE 
variables and to control the interaction with the devices in the field.  
 
When HFE approaches have been applied in the healthcare field positive results were achieved 
in enhancement of interaction with the device, patient safety, situation awareness and 
communication between clinicians and patients [see, for a review: 11,20]. Despite this there 
remains a gap between the medical field and other high-risk industries in the integration of HFE 
methods into healthcare practice [11,12,21]. This may in part be due to the fact that health 
professionals, without expertise or support of experts on HFE, are often asked to explore the 
usefulness of devices and/or to prevent and report device induced adverse events in the field 
[22].  
 
Human factors in medical field  
Lessons learned in healthcare field about errors show that human errors and adverse events in 
medicine are problems of human behaviour, capacities and engineering, not of medicine [23]. 
This does not means that health professionals do not have to deal with errors, but rather that 
medical experts need the assistance of HFE to avoid adverse events, to deal with errors, and to 
optimise the relationship between humans and devices in the context of use.  
HFE professionals in a healthcare environment may observe human behaviour, abilities, 
attitudes and limitations, and use these data to assess devices, to aid new design and, where 
necessary, to inform the redesign the broader sociotechnical systems and define the practices of 
use to enhance safety [24].  
Errors (i.e. any failure to perform an intended action that was correct given the circumstances 
[23]) may arise in a variety of ways in those complex sociotechnical environments where 
operators with different skills are required to use technologies. Each sociotechnical context can 
be characterized by specific workflows, culture, rules and constraints of communication, social 
interactions and a set of technologies. Due to their portability POC devices can be used in 
different contexts – e.g., from the clinical wards, triage centres, doctors’ ambulatory, to the home 
or in daily contexts of patients. These multiple environments of use, imply multiple end-users of 
the device with different expertise and roles, thus concurrently increasing the possibility of 
unsafe use and adverse events. Therefore, when an error does occur, the blaming of operators, 
users or manufacturers for that is generally an inappropriate and misleading concept [25]. Error 
could happen to anybody for many reasons, such as errors induced by poor design, unseen 
device faults, unsafe actions, lack of experience or training etc. However, errors in design or in 
the use of a device in addition to any unsafe and not well-planned practice may lead 
professionals to miss-diagnosis or to wrong diagnostic processes and expose patients to risks.  
HFE, particularly in health care, aims both to identify and model the possibility of errors and to 
support mitigation strategies. Evidence in the health care literature supports the idea that macro-
ergonomics approaches [11,12,20] – intended as the HFE applied to the work system design [26] 
– are appropriate practices in the medical field. Macro-ergonomics, by exploring the current 
practices in sociotechnical environments, serves the scope to improve the healthcare processes, 
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by reducing the likelihood of errors, time wasting and thereby enhance the service which in turn 
generates a positive experience for patients and their caregivers.  
An example of ‘macro-ergonomics’ are those system approaches which aim to model, observe 
and enhance the healthcare work environments, the contextual interactions, and healthcare 
quality and patient safety [21,27,28]. Concurrently HFE can be used by health professionals and 
administrators to map the device use – i.e., system mapping [29] – and to visually model the 
health care processes [30] to identify previously unrecognised opportunities in the context to 
improve patient safety, to define better care practices and to properly define the use of devices 
[31].  
Moreover, other HFE approaches for complex systems analysis can be applied to explore the 
healthcare sociotechnical system at a macro level, such as cognitive work analysis[32], work 
domain analysis [33], and hierarchical task analysis [34]. The holistic perspective of macro-
ergonomics, however, has to be integrated [35-37] with all those methods that aim to investigate 
people interactions with technologies at a micro (i.e., individual) level.  
Macro-ergonomics studies have an established place in enhancing the health care processes in 
terms of safety and use of the devices from organizational level whilst micro-ergonomics 
analyses, that mostly aim to observe in detail the interaction and the safety in use of devices at an 
individual level, are minimally performed in the field.  
Experts in HFE are increasingly looking to methods and frameworks to understand the 
relationships among micro-ergonomic variables (e.g., usability of a product, people reaction, 
satisfaction), and the rules and constraints of the health sociotechnical contexts usually studied at 
macro-ergonomics levels [38].  
Error-prone devices applied in safe and well-designed care process may introduce bias in the 
clinical outcomes – i.e., issues at micro-level may affect the larger ‘macro’ system. Alternatively, a 
poorly designed sociotechnical system may affect the performances in use of an, otherwise safe 
and usable, medical device thus comprising the delivery of healthcare – i.e., issues at macro-level 
may affect the micro one.  
In light of this, any interaction assessment has to include device evaluation in medical practice to 
fully understand and/or model the device use. This inclusion of HFE assessment in field studies 
is also supported by the ISO 62366 [13] that clearly outlines that the evaluation of interaction 
and use of medical devices cannot end once that the technology is available in the market.  
The variables required to assess the interaction are largely studied in other industry fields – 
automotive, aviation etc. [see, for a review: 39] – to observe and to identify unseen risks of use 
and possible miss-use induced by a wrong design. A full assessment of interaction, in tune with 
literature and standards [13,14,38-43] may include key variables, such as:  
- Acceptance of the device use. In line with the technology acceptance model [44,45] people’s 
decision to use or not use a device and their subsequent behaviour in use is affected by 
several factors. These include: i) perceived usefulness, ii) ease of use, and iii) attitude towards 
a device. Together with these factors, the evidence suggests that previous beliefs [46,47], as 
well as, their preference and experience with similar technology [48-50] may affect 
interaction by acting as a barrier or a facilitator to use. Acceptance, and it’s main variables, 
can be measured through well establish scales [44]. In HFE studies acceptance measures 
(i.e., perceived usefulness and attitudes toward the device) are also part of the assessment of 
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people expectations and reaction to the interaction, and are related to the evaluation of the 
satisfaction in use and user experience [48-50].  
- Usability. This is defined as effectiveness, efficiency and satisfaction of product usage in the 
specific context [42]. Usually, after a preliminary expert analysis of risk in use and 
simulations [13], usability is assessed through end-users tests to observe people 
performances and errors in use. Afterwards, users are asked to fill standardised satisfaction 
scales to gather data about the perceived usability of the tool.  
- User experience. This is defined as a person’s perceptions and responses that result from the 
use or anticipated use of a product, system or service [43]. This is a broad concept that 
includes and extends the usability assessment. User experience is measured through the 
time, and include the analysis of people performance, their satisfaction and attitudes – 
already included in the acceptance and usability assessment - but also the assessment of 
people preference, their emotional and physiological reaction to the aesthetics and the 
functioning of the product, as well as intention to use and the likelihood of promoting the 
product to colleagues. A wide set of methods [see, for a review: 51,52] can be applied to 
perform expert analysis of the device and observe effectiveness and efficiency of the 
interaction by testing performances in use (time, errors in use and achievement of tasks) and 
by also modelling the impact of previous abilities and skills. Moreover, well tested scales can 
be applied to assess user satisfaction [e.g., 53], intention to use, and experience in terms of 
expectations, reactions and preferences [e.g., 48,49,54].  
- Expectations before the device use and people reaction to the device during and after the 
use. Physiological reaction assessments are well established in HFE [for a review, see: 39], 
and usually test specific biofeedback technologies, or assess aspects such as the cognitive 
workload in the use of a device [e.g., see: NASA-Task Load Index instrument: 55]. 
Concurrently expectations may be assessed through quick scales [49,50] to capture pre- and 
post-use concerns and needs preferences These expectations strongly related to satisfaction 
of use, perceived usefulness, aesthetics and experience with the product [49,50] thus 
providing useful insights about the usability, intention of use, attitudes and acceptance of 
the product [48].  
Each one of these aspects is related to the others. Therefore, for instance, the assessment of user 
experience includes variables which are important also for the acceptance evaluation and vice 
versa. All the variables for the assessment are usually gathered through a very specific set of 
methods – such as verbal protocols, observation, scenario base analysis, task analysis– and well-
established evaluation scales [21,38-40] . Researchers may decide to extend the assessment by 
exploring a larger set of variables but, time constrains and costs usually limit these when 
measuring one or more aspects of the user’s interaction with a tool (Table 1). 
[TABLE 1 ABOUT HERE] 
 
This paper has selected and reviewed published studies that observed at least one interaction 
target measure. This survey of the literature aims to assess which: 
i) HFE aspects are currently explored in the healthcare studies on the use of POC  
ii) methods are applied to assess the target measure 
iii) variables are or are not considered in the medical field 
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Current clinicians’ perspective on interactive issues with POC devices  
To obtain an overall picture of the number of studies on POC devices, titles of journal and 
conference papers in PUBMED were searched with a set of keywords (see annex 1) applied in 
previous reviews [6,56]. This resulted in a set of 2,015 articles published 2000 to 2014, with 
publications increasing significantly over the period (see, Fig 1).  
[FIGURE 1 ABOUT HERE] 
 
Researchers have increasingly focused their attention on POC devices because these are 
considered the most reliable line of diagnostic technologies future development [57]. In 
literature, some work was done to control the interaction quality with interfaces of computer 
based POC tools [58,59]. Nevertheless, to our knowledge, no studies looked at the overall 
interaction with the physical device and its emended software. In tune with that, professionals 
raised several concerns and issues [4,6,60,61] related to marginally explored HFE aspects in the 
use and interaction of POC devices. Below we will discuss the issues reported in literature in 
terms of key HFE aspects of interaction assessment listed as follow: Acceptance, Usability and 
experience, and expectation and reactions.  
 
Acceptance 
Researchers identified concerns associated with attitudes, perceived usefulness and ease of use of 
POC devices. For example, when clinicians choose between POC testing and laboratory tests [6] 
they usually prefer to perform their diagnosis through the latter, or to double check POC 
outcomes with those from the laboratory [8]. This is because POC devices are, by their nature, 
tests performed in a less controlled environments and thereby potentially less accurate, than 
laboratory tests [8].  
Whilst the attitudes of general clinicians is to rely on POC outcomes, health care managers often 
express the concern that in future clinicians may over-rely on these devices [60]. This concern is 
around the potential for an increase in false-positive outcomes, leading to inappropriate 
diagnosis and treatments [6,8]. Although, qualitative data on acceptance are available in literature, 
in empirical studies of POC devices researchers usually gather data on only one index: the rate of 
acceptance of patients having (or clinicians using) a POC test [e.g., see: 62,63-65]. Although 
valuable, this does not inform researchers about the factors associated with acceptance – i.e., 
attitudes, usefulness, easiness of use. It is essential to understand these to assess whether or not 
the end-users (clinicians or patients) are going to use the device in future. For instance, patients 
and clinicians who accepted the use of a new POC device may, after a bad experience, decide to 
not use any more that rapid tests in the future. Similarly, a device with a high rate of acceptance, 
may then face barriers when it has to be adopted in the clinical practice due to unexplored issues 
in the users (patients and clinicians) experience with the device. 
Usability and user experience.  
Clinicians know the importance of usability for the quality of the POC use [66], and evidence 
shows that errors in use, as well as error in design could produce inaccurate results leading to 
inappropriate treatments [58]. Although the FDA [67] in the United States of America suggested 
that, when it is necessary, these kinds of interaction assessments can be included in clinical 
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studies, to date there are no available data in the literature about their inclusion in POC studies 
carried out in the field of usability and user experience methods. In tune with literature clinicians 
and patients satisfaction in use, perceived usefulness of POC devices and interaction with 
devices is not yet fully explored in clinical studies [4,6]. 
 
Expectations and reactions 
Evidence suggests [4,6] that POC devices are considered limited tools that can be used only in 
certain situations and with specific patients, or to deliver very limited diagnostic actions. 
Moreover, devices often appear problematic in terms of their functions and aesthetics even 
before use. Researchers have found that only a minimal proportion of portable POC device on 
the market are interoperable [19] and professionals could face several restrictions in terms of 
data exchange and integration due to different and not compatible formats. Moreover, 
professionals often reveal that the time needed, the time constraints and/or the lack of 
functionalities associated with the use of POC tools could create issues (stress, workload, 
frustration) for both clinicians and patients [68,69]. Nevertheless, preferences before use 
(expectations) and after use (reactions) as well as the induced stress or workload may affect the 
overall experience with a device, as well as the attitudes and the acceptance of the tools.  
 
Methods 
To explore the current application of HFE methods to assess the interaction with POC devices 
in the clinical and empirical studies we combined, through Boolean operators (AND / OR), the 
keywords related to POC devices (Annex 1) with a set of HFE keywords coming from: ISO 
62336 [13], the standard definition of usability [42] and user experience [43], and from OVID 
and IEEEXPLORE thesaurus (see Annex 2). We used these two set of keywords to scan both 
the title and the abstract of conference and journal papers published from 2000 to 2014 available 
in the following databases: PUBMED, OVID, IEEEXPLORE, and SCOPUS. One-hundred and 
fifty-nine articles were identified from this research. We excluded all the studies that did not 
present, or discuss methods and tools for the assessment of factors related to the interaction and 
use of products. Moreover we excluded studies focused only on usability assessment of software 
or computer based solutions for clinical decision making. Whereas, we included empirical studies 
carried out in medical field in which researchers, aiming at empirically explore or compare POC 
devices, also assessed one or more of the following three aspects of interactions: i) acceptance, ii) 
usability and experience, and iii) expectations and reaction to the device.  
 
Results 
Literature search 
Among the sample of 2,015 references, only 7.8% (159) directly refers to HFE aspects. After 
removing four duplicate citations, title and abstract screening excluded 18 and 41 articles, 
respectively. These were excluded because references were related to studies on software and 
interface inspections of device, or to POC devices in which the researcher explored only 
reported data about use or acceptance rate of the device without further investigation of these 
HFE aspects [e.g., see: 70,71]. Moreover, applying the pre-defined full text eligibility criteria to 
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the remaining references, 19 relevant articles were included. The process is described in detail in 
Figure 2. 
 
[FIGURE 2 ABOUT HERE] 
 
Characteristics of the selected studies  
Among the 19 included studies (see Table 2), 42.1% discussed POC for HIV [62-64,70-76], 
57.9% discussed the use of POC devices for other diseases – e.g., diabetes, myocardial infraction 
etc. – or the attitudes toward the POC technologies in the field [7,59,60,65,68,77-85]. 52.7% of 
the papers explored variables related to the analysis of performance, usability and experience in 
use, while 47.3% explored concepts related to the acceptance and attitude in use of POC device. 
Only in two studies (see Table 2) did researchers also explore variables related to expectations 
and reactions to the POC device [75,84]. Only 26.3% of the studies involved both patients and 
professionals, 42.1% of the studies only gathered patients’ perspective, and 31.6% only surveyed 
health professionals. Participant sample sizes of the reviewed articles varied greatly. Laurence et 
al. 2010 [7] involved 4968 patients, while Seto et al. 2006 [83] included only 4 health 
professionals. The number of participants was less than 100 in three studies, between 100 to less 
than 1000 in twelve cases, and over 1000 participants in four studies. 
 
[TABLE 2 ABOUT HERE] 
 
Applied methodologies to assess human factors and ergonomics aspects  
Seventeen out of nineteen studies applied a questionnaire alone, or associated to methods such 
as interviews or observations, while in the remaining studies participant’s experience after the 
device use was investigated through an interview. Although many studies were carried out by 
questionnaires, none of the reviewed studies referenced a validated instrument, or built 
assessment scales on the basis of available questionnaires in literature. Moreover, only in 7 of the 
19 cases were the set of questions applied in the study made available [7,64,65,68,74,75,83].  
Researchers were varied in their approach to the three interaction aspects, and in the 84.3% of 
the cases (see table 3) they failed to collect all the data needed to fully report on the target 
measure. In our database (see table 2):  
(i) Researchers who aimed to measure acceptance are mainly focussing on the overall rate of 
acceptance of the device use as a “one-measure-fits-all” solution. Acceptance rate is 
usually measured in terms of the number of people who accept or decline to use the test 
[e.g., see: 63,64,65,76,82,84], or as the number of clinicians who use or would like to use 
a rapid test instead, or together with, a lab test [62,72]. Moreover, to explore the reasons 
behind the acceptance, researchers often applied statistical analysis to control the effect 
of people’s characteristics and skills on the overall rate of acceptance. Concurrent 
questionnaires and interview were applied to explore patients and professionals’ attitudes 
towards the test and the possible barriers for the device use. No one of the studies, 
however, gathered data on ease of use and only in one case was the usefulness of the 
rapid test explored [82]. From the HFE point of view, acceptance factors – i.e., 
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usefulness, easiness of use and attitudes with the device – were only partially investigated 
in our dataset of POC studies.  
(ii) Only in one case [68] was experience measured by multiple assessment points to assess 
the experience gained after a sustained period of usage – e.g. after three months. While 
only in four cases [68,79,80,83] did researchers directly gather data about people 
performance – in terms of time, and errors in use/reading the results etc. This is a key 
step to measure efficacy and effectiveness dimensions of usability [42]. Satisfaction in 
use, which is the third metric of the usability, was measured in six studies 
[7,68,74,76,80,82,83]. However, only three of these studies [68,80,83] considered all the 
necessary factors to enable a satisfactory report about the usability of the device, while all 
other studies have measured, predominantly, the perceived use, usefulness or satisfaction 
in use of the device. 
(iii) Expectations and reactions variables were marginally included in two studies [75,84] in 
which researchers, by aiming to assess the acceptance and comparison of different 
versions of a device, also gathered data through scales, about people preferences after the 
use of the device. 
 
[TABLE 3 ABOUT HERE] 
 
Discussion 
This review has found a general lack of common and validated scales to measure HFE related 
variables in studies on POC devices. This is surprising as HFE methods, and interaction 
variables are well established across different industries. Moreover reliable scales are available to 
measure interaction factors. However, researchers on POC device have usually applied un-
validated scales that are often shaped for their specific objectives. This means that it is hard to 
reliably compare the findings from each study because some key factors are missing or have been 
evaluated with a different set of questions or with different approaches. Moreover in several 
cases the set of questions and scales are not presented or discussed in the articles, thus reducing 
the scope for comparative assessment. 
Our data showed that, although the rate of acceptance and the analysis of the effect of people 
characteristics on this rate are commonplace indicators in POC device, key aspects to fully 
explore the acceptance are often left unexplored. Conversely, studies that aim to assess usability 
and user experience with devices, generally gather enough data about user performance, with 
direct or indirect observation methods. However, even where this does happen researchers do 
not apply standardized scales to assess variables such as user satisfaction, perceived usefulness or 
likelihood of use. Also, expectations and reactions to the device, which are commonly measured 
in HFE studies [48,49], are often unexplored or only marginally analysed through qualitative 
questions about preferences after use.  
Our review has shown that clinical researchers have started to explore more HFE variables (11 
of the 19 studies were produced after 2009) but that these variables are generally only partially 
assessed in POC device studies. Moreover, a serious concern can be raised about the POC 
studies in the dataset, namely the lack of a holistic perspective on the people-device interaction 
assessment. As Stricklin and Struk [59] pointed out, POC device system functionalities will 
require continual adjustments, because integration in the context of use is an ongoing process, 
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and HFE is a main component of a successful implementation of POC technology in a complex 
sociotechnical setting, such as healthcare. Much of what we found was far removed from this 
sociotechnical approach. Often the studies assumed the device as usable without even testing the 
use of the tool in the context of use through an expert review (e.g., task analysis, cognitive 
walkthrough etc. [40,41]) or by a simulation of use through small pre-experimental group of 
operators. Therefore, acceptance studies (see Table 1) gather no insights about the effect of 
design errors, or user errors during the manipulation of the device on patients or insights into 
the clinicians’ attitudes toward the tool. Similarly, usability or experience studies do not report 
any information about previous expert analysis or studies on the devices, nor available 
manufacturers’ data on the usability of the tool. 
The lack of HFE approaches in POC studies strongly suggests, along with the findings of others 
[11,12,24,35], that the diffusion of HFE know-how in medicine could potentially generate new 
or enhanced evaluation paradigms to fully assess micro- and macro-ergonomics aspects of device 
interaction. This would help researchers to gather, through standardize and comparable scales, a 
fuller perspective on POC use and potential safety issues. Moreover, the holistic perspective 
embedded in HFE approaches may act as a proxy in the clinical field studies on POC and 
medical device to produce valuable insights that could lead to reduce ‘device recalls’ and induced 
adverse events.  
Potential users of the evidence retrieved should notice that studies have heterogeneous aims and 
highly variable numbers of participants (clinicians and patients). Despite this limitation, the 
current study provides both a comprehensive review of the current methods to survey HFE 
related variable in POC devices studies, and the current lacks in these studies.  
 
Expert commentary 
An increasing request of HFE contribution in the medical field is required in the literature 
[11,12,21,38]. However, we have found that HFE are partially or not applied in the clinical field, 
and often there is a lack of expertise to identify and properly assess the key variables of the 
interactions with and use of POC devices. This limited application HFE in the medical field 
could be due to myths and previous beliefs about HFE [12]. This must be addressed as there are 
at least three main advantages in the inclusion of HFE in the design of clinical and empirical 
studies on POC. These are:  
(i) By using well-established psychometric tools and validated scales, HFE experts may 
bring to medical field an effective way to compare and communicate their results on the 
use of POC devices, make replication of studies and evaluations easier, and facilitate 
reporting. (This is because researchers need only list the name of the questionnaire rather 
than reporting, in full, the development and content of, for example, a ‘home grown’ 
questionnaire [86]. ) 
(ii) HFE knowledge about the interaction with technologies brings a holistic perspective [59] 
to the medical field and generates important insights a) for those with responsibility for 
hospital procurement, b) for clinicians on how to use a POC device, c) about safety 
issues associated with the device, d) for reducing barriers of use across different wards 
and hospitals and e) for enhancing the level of acceptance of a new device for both 
clinicians and patients.  
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(iii) HFE expertise and knowledge may play a key role for extending and including new 
variables in clinical studies. For instance, to our knowledge, no studies are available in the 
literature on the “trust”, when in use, of a POC device. Trust in use is an emerging 
concept in the HFE field that is evaluated through a set of questions administrated 
before and after the use of a tool [46]. Trust is a measure of people’s beliefs towards a 
technology based on previous experience with similar devices that is strongly related to 
the acceptance. In fact, previous experience can generate a set of general belief, which 
may affect both people’s decision to use and attitudes toward a set of technologies or 
processes. For instance, a low level of trust in a set of products (general trust) may affect 
the trust in the use of a specific product (specific trust), thus decreasing the intention to 
use that product. However, trust is a dynamic concept and people can revise their 
previous belief. For instance some evidence, from the automotive field [47], shows that, 
independently from the initial general trust to a group of products/technology, products 
with a good level of usability may positively reshape people’s trust in the use of a specific 
product.  
 
In keeping with Kost’s concept of POC culture [87,88] people are today increasingly empowered 
by POC tools and they are developing skills to care for themselves through innovative 
technologies. This generates new and contextual forms of medical practices as well as new 
norms, behaviours, beliefs, attitudes and expectations toward devices. The POC culture varies 
from country to country, and different sociological and cultural factors affect the use (and the 
diffusion) of POC in different environments [89-92]. Unfortunately, this growing culture, is not 
yet aligned with our scientific knowledge of the key factors affecting the overall interaction and 
experience with devices. In fact, as we have shown in this article, factors – such as usability, 
experience of use, safety, satisfaction, expectation, attitudes and acceptance – are only marginally 
explored in the field, and are often reduced to simulation of use tests. These are usually with a 
small sample of users in laboratory environments or through the use of qualitative questionnaires 
with limited scope for comparison of results. HFE experts should embrace the concept of POC 
culture, and then promote clinical trials and analyses in the field of POC using standardised, 
rigorous approaches to enable scientific communities to explore and compare the multiple 
factors behind the safe and effective use of devices in differing cultural contexts and 
environments.  
    
Five-year view  
POC devices are considered a paradigm-shift in global healthcare [93]. These technologies are 
constantly evolving as tools to support home care, evidence-based personalized care, patient 
centred medicine, and preventive healthcare. In the future there will be a growing need to ensure 
the safety and the usability of these devices used both in hospitals and in the home [18,59,93], 
and to functionally integrate such technologies with the medical practices and contexts of use.  
The growing diffusion of POC devices is a direct result of the advancements in chemistry, 
materials and manufacturing. In the near future, advancements in manufacturing, tailoring 
process, materials and research in biomarkers and compounds will allow industries to produce 
cheaper devices, more integrated with the clinical field, with high levels of both specificity and 
sensitivity and with great levels of interoperability thus increasing the diagnostic answer and the 
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usefulness of POC tools. In all of this HFE will play a small part. We contend that, as happened 
for many other industrial products (e.g. such as mobile phones, tablets, computers etc.) HFE 
must play a key role in anticipating, understanding and avoiding current and future barriers in the 
effective and safe use of POC technology. The main contribution of HFE expertise integrated in 
the device development process and in the clinical studies will be to help manufacturers and 
clinicians to shape, revise and properly use the products. This will be achieved in keeping with 
end-users expectations and needs by minimizing the risks, enhancing the safety in use and 
ensuring that future integrated POC technologies conform to HF design principles [94]. In fact, 
the more POC devices become easy to use and diffused, then the more these technologies will 
weave themselves into the fabric of everyday life until they will be indistinguishable from other 
technologies [94]. The process of technology ‘disappearance’ has already started with POC tools 
that are, for instance, available and integrated into mobile applications (e.g., 
see: http://www.thyrometrix.com/; or http://www.colorimetrix.com/). Therefore, we are in the 
middle of an extraordinary evolution of the healthcare technologies, and HFE is a catalyst to the 
POC diffusion, use and enhancement [95] that will support manufactures and medical 
professionals in handling the future.  
POC technologies will become portable, faster and smarter. Probably, patients in the near future 
will receive not only the clinical results through POC systems, but they will also be required to 
use under skin sensors to: i) monitor their well-being over a time period, ii) communicate online 
with clinicians. Feedbacks to patients through smartphone technology is highly probable.  
While the medical field is rapidly progressing from the technological point of view, the 
methodological assessment of patient-clinicians interaction with devices has much to do. It is still 
far from achieving an integrated approach that could consider key aspects such as expectations 
(before and after the use), the context of use, cultural differences, and the end-user experience.  
HFE experts need to encourage developers and clinicians to utilise rigorous, scientific usability 
methods. There may also be a need to assess emotional reactions to measure explicit and implicit 
reactions during the interaction with a device. Such assessments may be achieved through 
biofeedback and algorithms to track facial expression, measure cognitive workload etc. [39] 
A holistic and well-integrated assessment of people experience with POC devices in the field will 
support and extend our understanding of patients and clinicians needs, errors of use and the 
barriers to adopting a product. 
An effective and efficient interaction is affected by several factors, therefore, a well-designed 
device experienced by people and clinicians in UK could have very differently reaction with users 
in other cultural settings where patients and clinicians may have different needs, expectations, 
habits and attitudes. Therefore, not only must usability and safety be considered by experts (to 
avoid miss-use and errors), but also the overall experience that supports the use and the 
acceptance of devices. Further research is therefore needed to enable clinicians and developers to 
embrace the idea that the human interaction assessment have to be performed in the field, 
instead of only in the lab, and use a robust scientific approach. This will reduce the uncertainty 
about the POC device use and will enhance the product design.  
In addition, there is a need to explore and diffuse new methods to assess, both implicitly and 
explicitly, the reaction of users (e.g. patients, clinicians) to such devices. This will also increase 
the ability to detect unmet needs, thus identifying potential new technical solutions for the 
healthcare market as well as informing current designs.  
D
ow
nl
oa
de
d 
by
 [P
ete
r B
uc
kle
] a
t 0
4:2
9 1
8 F
eb
ru
ary
 20
16
 
 Key issues  
• Clinicians are used to assuming that any device available on the market is both usable and 
safe; 
• Studies report the need for human factors and ergonomics methods to thoroughly 
explore the use and safety of POC; 
• Currently, only a minimal set of usability studies in the field are carried out on POC 
devices; 
• Usability metrics are only partially assessed through qualitative methods and do not 
generally use validated scales;  
• Acceptance of POC devices is usually assessed as “the number of patients/clinicians who 
accept using the tool” but most studies do not also consider the other key factors that 
contribute to acceptance; 
• Expectations and reactions to the device in use are only superficially included in the POC 
device studies; 
• Interaction and acceptance analyses are performed in the medical field often without 
referencing the methods used and/or the research related to the variables under 
assessment; 
• The scales applied in the human factor assessments are often ‘homemade’ and 
insufficiently developed, tested and reported. This reduces the reproducibility of the 
study and limits the scope for comparative analyses; 
• Human factors and ergonomics included in clinical studies may act as a catalyst to the 
future development of POC devices and to the modelling and understanding of both the 
current and future use of POC devices in the medical field; 
• Human factors/ergonomics experts have to embrace the concept of point of care culture 
by supporting clinicians and manufacturers to widen their perspective about the factors 
involved in the interaction with devices.  
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Target 
measure 
Key variables to meet the target Commonplace methodology 
Acceptance 
[see: 44,45] 
- Perceived usefulness 
- Easiness of use 
- Attitudes 
 
- Standardised questionnaire 
Usability [see: 
13,41,42] 
- Performance (errors and time) 
- Satisfaction 
- Direct Observation 
- Post use data gathering (video, 
notes, diary etc.) 
- Standardised scale 
Experience 
[see: 20,40,53] 
- Performance through the time 
- Satisfaction through the time 
- Emotional and physiological reactions 
- Direct Observation 
- Post use data gathering (video, 
notes, diary etc.) 
- Standardised scale 
Expectations 
[see: 49,50,53] - Preference before and after the use - Tested scales 
Reaction 
[see: 39,54,55] 
- Physiological reactions such as stress, cognitive 
workload, attention and attractiveness  
- Biofeedback instruments, 
standardised scales 
Table 1. Target measure of interaction assessment with technology, minimal set of variables to 
achieve the target, and commonplace methodology for the assessment. 
 
Study Participants 
n. and types 
HFE related aspects Assessment Methods 
Interaction aspect  Observed HFE variables  
Agustí et al. 
2013 [72] 1308 clinicians 
 
- Acceptance 
 
- Acceptance rate 
- Attitudes 
- Barriers of use 
- Questionnaire Agustí et al. 
2013 [62] 
Note: Authors used a similar set of data and method to look mainly at attitudes toward POC [72] or at acceptability of POC [62] 
Bello et al. 2011 
[63] 104 patients - Acceptance 
- Acceptance rate 
- Reasons 
- Interview 
- Questionnaire  
Bienek et al. 
2013 [79] 377 patients 
- Usability and 
experience 
- Errors in use 
- Results interpretation 
- People skills impact 
- Observation 
- Questionnaire 
Cals et al. 2010 
[60] 20 clinicians 
- Usability and 
experience 
- Perceived experience 
- Attitudes - Interview 
Chen et al. 2011 
[74] 
121 patients 
22 clinicians 
- Usability and 
experience 
- Easiness of use 
- Satisfaction 
- Facilitators of use 
- Interview  
- Questionnaire 
Conners et al. 
2012 [73] 
835 patients 
18 clinicians - Acceptance  
- Experienced barriers  
- Attitudes 
- Interview 
- Questionnaire 
Ferris et al. 2003 
[84] 374 patients 
- Acceptance 
- Expectations and 
reactions 
- Acceptance rate 
- Reasons  
- Barriers of use 
- Preferences in use 
- Questionnaire 
- Comparison of devices 
solutions 
Iqbal et al. 2014 
[64] 92 patients - Acceptance  
- Acceptance rate 
- Reasons 
- Concerns before the 
test/attitudes 
- Questionnaire 
Kong et al. 2008 
[82] 230 patients - Acceptance  
- Acceptance rate 
- Satisfaction 
- Usefulness  
- Interview and 
Questionnaire 
Kost 2001 [85] 212 clinicians - Usability and experience 
- Performance in use 
- Perceived safety 
- Features of POC 
- Questionnaire 
Laurence et al. 
2008 [68] 
115 patients 
58 clinicians 
- Usability and 
experience 
- Performance 
- Perceived Safety 
- Attitudes toward  
- Satisfaction 
- Clinicians notes 
- Questionnaire (through 
a period of time) 
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Laurence et al. 
2010 [7] 4968 patients 
- Usability and 
experience - Satisfaction  - Questionnaire 
Mayega et al. 
2014 [77] 
795 patients 
24 clinicians 
- Usability and 
experience 
- Easiness of use 
- Perceived use 
- Reversible and 
irreversible mistakes 
- Errors in use  
- Interview  
Merchant et al. 
2009 [75] 2155 patients 
- Usability and 
experience 
- Expectations and 
reactions 
- Preferences of use 
- Perceived usefulness 
- Perceived 
performance  
- Questionnaire 
Schalkwyk et al. 
2008 [65] 
226 patients 
51 clinicians - Acceptance 
- Attitudes toward a 
new POC device - Questionnaire  
Seto et al. 2006 
[83] 4 clinicians 
- Usability and 
experience 
- Performance 
- Satisfaction  
- Observation  
- Verbal protocol 
- Questionnaire 
Shephard et al. 
2012 [80] 161 clinicians 
- Usability and 
experience 
- Performance  
- Satisfaction 
- Observation 
- Questionnaire 
Wurcel et al. 
2005 [76] 203 patients - Acceptance 
- Acceptance rate 
- Reasons 
- Interview 
- Questionnaire 
Table 2. Summary of selected outcomes. 
 
Study HFE related aspects Unexplored 
variables Interaction aspect  Observed HFE variables  
Agustí et al. 2013 [72] 
- Acceptance 
- Acceptance rate 
- Attitudes 
- Barriers of use 
- Perceived 
usefulness 
- Easiness of use Agustí et al. 2013 [62] 
Bello et al. 2011 [63] - Acceptance - Acceptance rate - Reasons 
- Perceived 
usefulness 
- Easiness of use 
- Attitudes toward 
test 
Bienek et al. 2013 [79] - Usability and experience 
- Errors in use 
- Results interpretation 
- People skills impact 
- Satisfaction 
Cals et al. 2010 [60] - Usability and experience - Perceived experience - Attitudes 
- Performance  
- Satisfaction 
Chen et al. 2011 [74] 
- Usability and experience - Easiness of use 
- Satisfaction 
- Facilitators of use 
- Performance  
Conners et al. 2012 
[73] - Acceptance  
- Experienced barriers  
- Attitudes - Performance  
Ferris et al. 2003 [84] 
- Acceptance 
- Expectations and 
reactions 
- Acceptance rate 
- Reasons  
- Barriers of use 
- Preferences in use 
- Perceived 
usefulness 
- Easiness of use 
- Attitudes toward 
test 
Iqbal et al. 2014 [64] - Acceptance  
- Acceptance rate 
- Reasons 
- Concerns before the 
test/attitudes 
- Perceived 
usefulness 
- Easiness of use 
Kong et al. 2008 [82] - Acceptance  
- Acceptance rate 
- Satisfaction 
- Usefulness  
- Perceived 
usefulness 
- Easiness of use 
Kost 2001 [85] - Usability and experience 
- Performance in use 
- Perceived safety 
- Features of POC 
- Satisfaction 
Laurence et al. 2008 
[68] - Usability and experience 
- Performance 
- Perceived Safety -- 
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- Attitudes toward  
- Satisfaction 
Laurence et al. 2010 
[7] 
- Usability and experience - Satisfaction  Performance  
Mayega et al. 2014 [77] - Usability and experience 
- Easiness of use 
- Perceived use 
- Reversible and irreversible 
mistakes 
- Errors in use  
- Satisfaction 
Merchant et al. 2009 
[75] 
- Usability and experience 
- Expectations and 
reactions 
- Preferences of use 
- Perceived usefulness 
- Perceived performance  
- Performance  
- Satisfaction 
Schalkwyk et al. 2008 
[65] - Acceptance 
- Attitudes toward a new POC 
device 
- Perceived 
usefulness 
- Easiness of use 
Seto et al. 2006 [83] - Usability and experience - Performance - Satisfaction  -- 
Shephard et al. 2012 
[80] - Usability and experience 
- Performance  
- Satisfaction -- 
Wurcel et al. 2005 [76] - Acceptance - Acceptance rate - Reasons 
- Perceived 
usefulness 
- Easiness of use 
- Attitudes toward 
test 
 
Table 3. Factors investigated and missing factors. Table shows expectations and reactions are 
rarely explored in clinical studies of POC devices; non-validated scales are usually utilised; 
acceptance, usability and experience variables are (at the very least) partially measured; several 
key HFE aspects are left unexplored in such studies. 
 
 
 
Figure 1. Number of journal and conference papers on POC devices from 2000 to 2014 in 
PUBMED.  
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Figure 2. Flow diagram of study identification and selection 
 
 
 
ANNEX 1. List of keywords related to point of care devices 
Immediate, rapid, same time, near patient, portable, bedside, bed-side, POC testing, in vitro, in 
vitro diagnostics, POCT, point of care, Point-of-Care test, analysis, measure, systems, device, and 
technology. 
Operators (AND/OR) 
 
ANNEX 2. List of Human factors and ergonomics keywords  
Human Factors, Ergonomics, usability engineering, Process mapping, Clinical pathways, Work 
domain analysis, HTA, Regulatory, Standards, Preference, Acceptance, safety, perceived safety, 
use error(s), user error(s), handling, satisfaction, usability, easiness of use, User Needs, User 
experience, people attitude, effectiveness in use, efficiency in use, context of use, intended use, 
Human Factors Engineering, Performance Technology; Use Studies; User Satisfaction 
(Information); quality control; User friendliness; Human engineering; Affective interaction. 
Operators (AND/OR) 
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